Media centre

Press releases

To be notified when a new press release is added to this site please register with our alert service.

Date	Title
16/06/2008	Antisoma announces AS1413 (Xanafide) presentation at EHA
11/06/2008	Antisoma completes acquisition of Xanthus Pharmaceuticals Inc.
09/06/2008	EGM resolutions passed
01/06/2008	Positive data on Antisoma’s ASA404 presented at ASCO
30/05/2008	Antisoma announces positive ASA404 presentations at ASCO
29/05/2008	Antisoma receives USD 25 million milestone payment from Novartis
19/05/2008	Prospectus posted and EGM date announced for Antisoma's acquisition of Xanthus Pharmaceuticals and related fundraising
16/05/2008	Antisoma to present at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo
16/05/2008	Antisoma to acquire Xanthus
29/04/2008	Antisoma Interim Management Statement
16/04/2008	AACR presentation illustrates broad potential of Antisoma’s AS1411 in blood cancers
14/04/2008	Antisoma licenses rights to develop Betagenon’s AMPK activators as cancer treatments
11/04/2008	Antisoma announces start of phase III lung cancer trial of ASA404
08/04/2008	Data on AS1411 action in breast cancer cells published in Cancer Research
17/03/2008	Antisoma to present at Cowen and Company Conference
21/02/2008	Antisoma plc reports half-year results
21/02/2008	Antisoma starts phase I clinical trial of AS1409 in renal cancer and melanoma
08/02/2008	Antisoma to present at BIO CEO & Investor Conference in New York
02/01/2008	Antisoma to present at JP Morgan conference